Gilead Sciences, Inc.
GILD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3,052,000 | $1,960,000 | $1,315,000 | $1,783,000 |
| Dep. & Amort. | $686,000 | $691,000 | $696,000 | $693,000 |
| Deferred Tax | $659,000 | -$178,000 | -$199,000 | -$379,000 |
| Stock-Based Comp. | $230,000 | $225,000 | $209,000 | $222,000 |
| Change in WC | -$297,000 | -$2,014,000 | -$1,033,000 | $483,000 |
| Other Non-Cash | -$222,000 | $143,000 | $769,000 | $173,000 |
| Operating Cash Flow | $4,108,000 | $827,000 | $1,757,000 | $2,975,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$147,000 | -$107,000 | -$104,000 | -$147,000 |
| Net Acquisitions | -$167,000 | -$21,000 | -$273,000 | -$75,000 |
| Inv. Purchases | -$352,000 | -$2,308,000 | -$16,000 | -$39,000 |
| Inv. Sales/Matur. | $236,000 | $310,000 | $0 | $0 |
| Other Inv. Act. | $3,000 | $10,000 | -$22,000 | $36,000 |
| Investing Cash Flow | -$427,000 | -$2,116,000 | -$415,000 | -$225,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$9,000 | -$9,000 | -$1,762,000 | $3,457,000 |
| Stock Issued | $97,000 | $27,000 | $252,000 | $173,000 |
| Stock Repurch. | -$435,000 | -$527,000 | -$730,000 | -$350,000 |
| Dividends Paid | -$1,005,000 | -$994,000 | -$1,010,000 | -$973,000 |
| Other Fin. Act. | -$137,000 | -$64,000 | -$176,000 | -$47,000 |
| Financing Cash Flow | -$1,489,000 | -$1,567,000 | -$3,426,000 | $2,260,000 |
| Forex Effect | -$5,000 | $73,000 | $19,000 | -$55,000 |
| Net Chg. in Cash | $2,186,000 | -$2,782,000 | -$2,065,000 | $4,954,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,144,000 | $7,926,000 | $9,991,000 | $5,037,000 |
| End Cash | $7,330,000 | $5,144,000 | $7,926,000 | $9,991,000 |
| Free Cash Flow | $3,961,000 | $720,000 | $1,653,000 | $2,828,000 |